On 23 January 2024, the applicant withdrew the application as regards the recognition of the compatibility of use of the preparation of Weizmannia faecalis DSM 32016 with the following coccidiostats: narasin, a combination of narasin with nicarbazin, decoquinate, lasalocid A sodium, semduramicin sodium, nicarbazin, amprolium hydrochloride.
Recital 6, Regulation (EU) 2024/1054
In forcesince 10 Apr 2024